Physician Assistant, Medical · Columbia, MD
NPI
1902903990
Since 2006
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
10710 Charter Dr, Suite G020
Columbia, MD, 21044
Phone (410) 964-2212
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,326
82 services
Medicare patients, 2024
75
Average age 76
Drug cost, 2024
$4.1M
1,317 prescriptions
Company payments, 2025
$4,262
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam R Schmuckler was code 99204 (office e&m - new), 35 times for 35 patients. In total Adam R Schmuckler billed 82 services in 15 codes, and Medicare paid $7,326.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99204 Office E&M - New | Office | 35 | 35 | $112.17 | $3,926 |
| 99213 Office E&M - Established | Office | 11 | 11 | $58.79 | $647 |
By year: 2022 $4,648 for 53 services; 2023 $6,556 for 85 services; 2024 $7,326 for 82 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adam R Schmuckler prescribed most often to Medicare patients was Eliquis (Apixaban), with 178 prescriptions and refills. In total Adam R Schmuckler wrote 1,317 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 178 | 238 | 45 | $137K |
| Acyclovir Generic | 108 | 166 | 17 | $1,528 |
| Anastrozole Generic | 102 | 240 | 27 | $2,151 |
| Xarelto Rivaroxaban | 65 | 121 | 21 | $63K |
| Letrozole Generic | 56 | 149 | 18 | $1,517 |
| Hydroxyurea Generic | 53 | 120 | 18 | $1,273 |
| Brukinsa Zanubrutinib | 41 | 41 | Under 11 | $617K |
| Ninlaro Ixazomib Citrate | 39 | 41 | Under 11 | $524K |
| Prednisone Generic | 36 | 40 | 12 | $146 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 30 | 61 | Under 11 | $233 |
| Ondansetron Hcl Generic | 29 | 32 | 17 | $329 |
| Imbruvica Ibrutinib | 28 | 28 | Under 11 | $463K |
| Jakafi Ruxolitinib Phosphate | 27 | 27 | Under 11 | $451K |
| Warfarin Sodium Generic | 25 | 39 | Under 11 | $112 |
| Tamoxifen Citrate Generic | 24 | 54 | Under 11 | $762 |
Brand drugs: 508 claims; generic drugs: 809 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam R Schmuckler $4,262 ($4,262 in general payments such as food, travel and fees) from 45 companies. The largest payer was Novartis Pharmaceuticals Corporation with $442.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 20 | $442 |
| Pfizer Inc. PFE | 16 | $403 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $388 |
| Janssen Biotech, Inc. JNJ | 8 | $328 |
| BeOne Medicines USA, Inc. ONC | 6 | $244 |
| Genentech USA, Inc. ROG.SW | 7 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $143 |
| Daiichi Sankyo Inc. 4568.T | 4 | $114 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.